CADL R&D Expense Growth
Candel Therapeutics Inc · R&D Expense Growth
CADL R&D Expense Growth
Latest reported57.90%period ending
CADL FY R&D Growth (YoY) (0.00% → 57.90%)
Latest values, visible window
High-resolution chart · PNG
CADL r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 57.8958% | |
| -21.1866% | |
| 17.891% | |
| 36.9548% | |
| 73.3836% | |
| 32.4958% | |
| 0% |